Biomolecular Life Holdings, Inc. (BIOM)
OTCMKTS · Delayed Price · Currency is USD
0.4700
0.00 (0.00%)
At close: Sep 23, 2026

BIOM Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013FY 2012
Period EndingMar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-0.3-0.3-0.26-4.14-3.91-2.6
Net Income
-0.61-0.35-0.22-6.19-7.42-6.85
Earnings Per Share
-0.57-0.33-0.21---
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2014FY 2013FY 2012
Period EndingMar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Cash & Investments
0000.030.710.01
Total Debt
0.50.490.453.863.213.57
Net Cash (Debt)
-0.5-0.49-0.45-3.83-2.49-3.56
Net Cash Growth
------
Net Cash Per Share
-0.47-0.46-0.42---

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013FY 2012
Period EndingMar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Operating Cash Flow
-0.06-0.06-0.02-1.91-1.04-0.96
Capital Expenditures
------
Free Cash Flow
-0.06-0.06-0.02-1.91-1.04-0.96
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2014FY 2013FY 2012
Period EndingMar '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2014FY 2013FY 2012
Period EndingSep '26 Dec '25 Dec '24 Dec '14 Dec '13 Dec '12
PS Ratio
------